Author Search Results :: UTM Library Massive Scholar Tracking

1

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin by Thorlund K, Druyts E, Mills EJ

Published 2014-01-01

Get full text

Article
2

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis by Ghement I, Druyts E, Mills EJ, Puhan MA

Published 2011-03-01

Get full text

Article
3

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection by El Khoury AC, Druyts E, Thorlund K, Mills EJ

Published 2012-11-01

Get full text

Article
4

Incorporating alternative design clinical trials in network meta-analyses by Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ

Published 2014-12-01

Get full text

Article
5

Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review by Yan K, Desai K, Gullapalli L, Druyts E, Balijepalli C

Published 2020-03-01

Get full text

Article
6

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection by Druyts E, Thorlund K, Humphreys S, Lion M, Cooper CL, Mills EJ

Published 2013-06-01

Get full text

Article
7

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes by Balijepalli C, Druyts E, Siliman G, Joffres M, Thorlund K, Mills EJ

Published 2017-05-01

Get full text

Article
8

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis by Thorlund K, Druyts E, Avi&ntilde;a-Zubieta JA, Mills EJ

Published 2012-12-01

Get full text

Article
9

Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis by O&#39;Regan C, Nachega J, Mills EJ, Druyts E, Cooper CL

Published 2012-02-01

Get full text

Article
10

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in He... by Balijepalli C, Gullapalli L, Druyts E, Yan K, Desai K, Barakat S, Locklin J

Published 2020-08-01

Get full text

Article
11

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda by Kanters S, Nansubuga M, Mwehire D, Odiit M, Kasirye M, Musoke W, Druyts E, Yaya S, Funk A, Ford N, Mills EJ

Published 2013-05-01

Get full text

Article